Controlling the frontier: Regulatory T-cells and intestinal homeostasis

Seminars in Immunology

Volumn 25, Issue 5, 2013, Pages 352-357

  Bollrath, Julia ^a   Powrie, Fiona M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Inflammatory bowel disease; Intestine; Microbiota; Regulatory T cells

Indexed keywords

CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; COLITIS; CROHN DISEASE; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INTESTINE; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION;

INFLAMMATORY BOWEL DISEASE; INTESTINE; MICROBIOTA; REGULATORY T-CELLS;

ANIMALS; BACTERIA; HOMEOSTASIS; HUMANS; INTESTINES; MICROBIOTA; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84888872209     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.09.002     Document Type: Review

References (94)

1. Abt M.C., Osborne L.C., Monticelli L.A., Doering T.A., Alenghat T., Sonnenberg G.F., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
2. Hand T.W., Dos Santos L.M., Bouladoux N., Molloy M.J., Pagan A.J., Pepper M., et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 2012, 337:1553-1556.
3. Powrie F., Leach M.W., Mauze S., Caddle L.B., Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C B-17 scid mice. International Immunology 1993, 5:1461-1471.
4. Powrie F., Mason D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. The Journal of Experimental Medicine 1990, 172:1701-1708.
5. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995, 155:1151-1164.
6. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. The Journal of Experimental Medicine 1996, 184:387-396.
7. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nature Immunology 2003, 4:330-336.
8. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
9. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+ CD25+ T regulatory cells. Nature Immunology 2003, 4:337-342.
10. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 2001, 27:20-21.
11. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004, 21:267-277.
12. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000, 12:431-440.
13. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunology 2005, 6:1142-1151.
14. Bayer A.L., Lee J.Y., de la Barrera A., Surh C.D., Malek T.R. A function for IL-7R for CD4+ CD25+ Foxp3+ T regulatory cells. Journal of Immunology 2008, 181:225-234.
15. Vang K.B., Yang J., Mahmud S.A., Burchill M.A., Vegoe A.L., Farrar M.A. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development. Journal of Immunology 2008, 181:3285-3290.
16. Marie J.C., Letterio J.J., Gavin M., Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells. The Journal of Experimental Medicine 2005, 201:1061-1067.
17. Ouyang W., Beckett O., Ma Q., Li M.O. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32:642-653.
18. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+ CD25-naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of Experimental Medicine 2003, 198:1875-1886.
19. Zheng S.G., Wang J.H., Gray J.D., Soucier H., Horwitz D.A. Natural and induced CD4+ CD25+ cells educate CD4+ CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. Journal of Immunology 2004, 172:5213-5221.
20. Benson M.J., Pino-Lagos K., Rosemblatt M., Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. The Journal of Experimental Medicine 2007, 204:1765-1774.
21. Zheng S.G., Wang J.H., Stohl W., Kim K.S., Gray J.D., Horwitz D.A. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells. Journal of Immunology 2006, 176:3321-3329.
22. Barnes M.J., Griseri T., Johnson A.M., Young W., Powrie F., Izcue A. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria. Mucosal Immunology 2013, 6:324-334.
23. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
24. Josefowicz S.Z., Niec R.E., Kim H.Y., Treuting P., Chinen T., Zheng Y., et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012, 482:395-399.
25. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
26. Geuking M.B., Cahenzli J., Lawson M.A., Ng D.C., Slack E., Hapfelmeier S., et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011, 34:794-806.
27. Kim S.V., Xiang W.V., Kwak C., Yang Y., Lin X.W., Ota M., et al. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 2013, 340:1456-1459.
28. Kenny E.F., O'Neill L.A. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008, 43:342-349.
29. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. The Journal of Experimental Medicine 2007, 204:1757-1764.
30. Weiss J.M., Bilate A.M., Gobert M., Ding Y., Curotto de Lafaille M.A., Parkhurst C.N., et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. The Journal of Experimental Medicine 2012, 209:1723-1742. S1721.
31. Yadav M., Louvet C., Davini D., Gardner J.M., Martinez-Llordella M., Bailey-Bucktrout S., et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. The Journal of Experimental Medicine 2012, 209:1713-1722. S1711-S1719.
32. Delgoffe G.M., Woo S.R., Turnis M.E., Gravano D.M., Guy C., Overacre A.E., et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 2013, 501:252-256.
33. Lathrop S.K., Bloom S.M., Rao S.M., Nutsch K., Lio C.W., Santacruz N., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478:250-254.
34. Cebula A., Seweryn M., Rempala G.A., Pabla S.S., McIndoe R.A., Denning T.L., et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013, 497:258-262.
35. Haribhai D., Williams J.B., Jia S., Nickerson D., Schmitt E.G., Edwards B., et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011, 35:109-122.
36. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nature Reviews Immunology 2008, 8:523-532.
37. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annual Review of Immunology 2009, 27:313-338.
38. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
39. Marie J.C., Liggitt D., Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006, 25:441-454.
40. Fahlen L., Read S., Gorelik L., Hurst S.D., Coffman R.L., Flavell R.A., et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. The Journal of Experimental Medicine 2005, 201:737-746.
41. Li M.O., Flavell R.A. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008, 28:468-476.
42. Li M.O., Wan Y.Y., Flavell R.A. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007, 26:579-591.
43. Travis M.A., Reizis B., Melton A.C., Masteller E., Tang Q., Proctor J.M., et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007, 449:361-365.
44. Pesu M., Watford W.T., Wei L., Xu L., Fuss I., Strober W., et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 2008, 455:246-250.
45. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
46. Kullberg M.C., Ward J.M., Gorelick P.L., Caspar P., Hieny S., Cheever A., et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infection and Immunity 1998, 66:5157-5166.
47. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
48. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., Regulatory T., et al. cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
49. Asseman C., Mauze S., Leach M.W., Coffman R.L., Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. The Journal of Experimental Medicine 1999, 190:995-1004.
50. Maynard C.L., Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., Regulatory T., et al. cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nature Immunology 2007, 8:931-941.
51. Uhlig H.H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., et al. Characterization of Foxp3+ CD4+ CD25+ and IL-10-secreting CD4+ CD25+ T cells during cure of colitis. Journal of Immunology 2006, 177:5852-5860.
52. Chaudhry A., Samstein R.M., Treuting P., Liang Y., Pils M.C., Heinrich J.M., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011, 34:566-578.
53. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature Immunology 2009, 10:1178-1184.
54. Kullberg M.C., Jankovic D., Gorelick P.L., Caspar P., Letterio J.J., Cheever A.W., et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. The Journal of Experimental Medicine 2002, 196:505-515.
55. Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schaffer A.A., Noyan F., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. The New England Journal of Medicine 2009, 361:2033-2045.
56. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
57. Collison L.W., Chaturvedi V., Henderson A.L., Giacomin P.R., Guy C., Bankoti J., et al. IL-35-mediated induction of a potent regulatory T cell population. Nature Immunology 2010, 11:1093-1101.
58. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
59. Chung H., Pamp S.J., Hill J.A., Surana N.K., Edelman S.M., Troy E.B., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012, 149:1578-1593.
60. Nava G.M., Friedrichsen H.J., Stappenbeck T.S. Spatial organization of intestinal microbiota in the mouse ascending colon. The ISME Journal 2011, 5:627-638.
61. Bry L., Falk P.G., Midtvedt T., Gordon J.I. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996, 273:1380-1383.
62. Reinhardt C., Bergentall M., Greiner T.U., Schaffner F., Ostergren-Lunden G., Petersen L.C., et al. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 2012, 483:627-631.
63. Ley R.E., Hamady M., Lozupone C., Turnbaugh P.J., Ramey R.R., Bircher J.S., et al. Evolution of mammals and their gut microbes. Science 2008, 320:1647-1651.
64. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:13780-13785.
65. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52:237-242.
66. Kotlowski R., Bernstein C.N., Sepehri S., Krause D.O. High prevalence of Escherichia coli belonging to the B2+ D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669-675.
67. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory Bowel Diseases 2009, 15:1183-1189.
68. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:16731-16736.
69. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
70. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host & Microbe 2010, 8:292-300.
71. Carvalho F.A., Koren O., Goodrich J.K., Johansson M.E., Nalbantoglu I., Aitken J.D., et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host & Microbe 2012, 12:139-152.
72. van Maren W.W., Jacobs J.F., de Vries I.J., Nierkens S., Adema G.J. Toll-like receptor signalling on Tregs: to suppress or not to suppress?. Immunology 2008, 124:445-452.
73. Dai J., Liu B., Li Z. Regulatory T cells and Toll-like receptors: what is the missing link?. International Immunopharmacology 2009, 9:528-533.
74. Workman C.J., Collison L.W., Bettini M., Pillai M.R., Rehg J.E., Vignali D.A. In vivo Treg suppression assays. Methods in Molecular Biology 2011, 707:119-156.
75. Fukata M., Breglio K., Chen A., Vamadevan A.S., Goo T., Hsu D., et al. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. Journal of Immunology 2008, 180:1886-1894.
76. Asquith M.J., Boulard O., Powrie F., Maloy K.J. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology 2010, 139(519-529):e511-e512. 529.
77. Duan L., Chen J., Zhang H., Yang H., Zhu P., Xiong A., et al. Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) regulatory T-cell responses in mice. Molecular Medicine 2012, 18:753-761.
78. Oertli M., Sundquist M., Hitzler I., Engler D.B., Arnold I.C., Reuter S., et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. The Journal of Clinical Investigation 2012, 122:1082-1096.
79. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., Kullberg B.J., et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. The Journal of Clinical Investigation 2006, 116:485-494.
80. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
81. Boulard O., Asquith M.J., Powrie F., Maloy K.J. TLR2-independent induction and regulation of chronic intestinal inflammation. European Journal of Immunology 2010, 40:516-524.
82. Hardenberg G., Yao Y., Piccirillo C.A., Levings M.K., Steiner T.S. Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor-beta-deficient mice. Inflammatory Bowel Diseases 2012, 18:85-93.
83. Peng G., Guo Z., Kiniwa Y., Voo K.S., Peng W., Fu T., et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005, 309:1380-1384.
84. Rahman M.K., Midtling E.H., Svingen P.A., Xiong Y., Bell M.P., Tung J., et al. The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. Journal of Immunology 2010, 184:7247-7256.
85. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
86. Izcue A., Hue S., Buonocore S., Arancibia-Carcamo C.V., Ahern P.P., Iwakura Y., et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008, 28:559-570.
87. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
88. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
89. Xu L., Kitani A., Stuelten C., McGrady G., Fuss I., Strober W. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 2010, 33:313-325.
90. Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
91. Hall A.O., Beiting D.P., Tato C., John B., Oldenhove G., Lombana C.G., et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 2012, 37:511-523.
92. Hall J.A., Bouladoux N., Sun C.M., Wohlfert E.A., Blank R.B., Zhu Q., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
93. Bouladoux N., Hall J.A., Grainger J.R., dos Santos L.M., Kann M.G., Nagarajan V., et al. Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunology 2012, 5:623-634.
94. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.